Login / Signup

SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone.

S M A AhmedM VolontèE IsolettaC VassalloC F TomasiniD LilleriP ZeliniV MusellaC KlersyValeria Brazzelli
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Keyphrases
  • sars cov
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • mesenchymal stem cells